Table 3.
Characteristic | Patients, n | Percentage of adherencea, mean (SD) | P valueb | |||||||
Sex | .65 | |||||||||
|
Female | 356 | 70.7 (23.1) |
|
||||||
|
Male | 302 | 69.8 (25.7) |
|
||||||
Age (years) | .02 | |||||||||
|
<18 | 44 | 60.3 (25.7) |
|
||||||
|
18-25 | 91 | 66.3 (24.3) |
|
||||||
|
26-35 | 111 | 69.7 (22.6) |
|
||||||
|
36-45 | 117 | 71.1 (24.5) |
|
||||||
|
46-55 | 165 | 73 (22.5) |
|
||||||
|
56-65 | 86 | 75.6 (25) |
|
||||||
|
66-75 | 36 | 67 (29.6) |
|
||||||
Age group (years) | .02 | |||||||||
|
<36 | 246 | 66.8 (23.9) |
|
||||||
|
36-55 | 282 | 72.2 (23.3) |
|
||||||
|
>55 | 133 | 72.8 (26.4) |
|
||||||
Age group per sex (years) | .05 | |||||||||
|
<36 |
|
||||||||
|
|
Female | 144 | 66 (24.3) |
|
|||||
|
|
Male | 102 | 67.8 (23.4) |
|
|||||
|
36-55 |
|
||||||||
|
|
Female | 149 | 72.9 (21.8) |
|
|||||
|
|
Male | 133 | 71.4 (25) |
|
|||||
|
>55 |
|
||||||||
|
|
Female | 63 | 76 (21.7) |
|
|||||
|
|
Male | 67 | 69.8 (30) |
|
aAdherence was restricted to patients with ≥90 days since the start of medication; data includes day 90.
bP values are based on analysis of variance tests for continuous variables and the chi-square test for categorical variables.